- Home
- DNA vs PRME Comparison
DNA vs PRME Comparison
Compare DNA & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNA
- PRME
- Stock Information
- Founded
- DNA 2008
- PRME 2019
- Country
- DNA United States
- PRME United States
- Employees
- DNA N/A
- PRME N/A
- Industry
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- PRME Medicinal Chemicals and Botanical Products
- Sector
- DNA Health Care
- PRME Health Care
- Exchange
- DNA Nasdaq
- PRME Nasdaq
- Market Cap
- DNA 731.1M
- PRME 693.5M
- IPO Year
- DNA N/A
- PRME 2022
- Fundamental
- Price
- DNA $14.93
- PRME $5.95
- Analyst Decision
- DNA Strong Sell
- PRME Buy
- Analyst Count
- DNA 1
- PRME 6
- Target Price
- DNA $9.00
- PRME $8.88
- AVG Volume (30 Days)
- DNA 1.7M
- PRME 3.9M
- Earning Date
- DNA 11-11-2025
- PRME 11-11-2025
- Dividend Yield
- DNA N/A
- PRME N/A
- EPS Growth
- DNA N/A
- PRME N/A
- EPS
- DNA N/A
- PRME N/A
- Revenue
- DNA $230,815,000.00
- PRME $4,961,000.00
- Revenue This Year
- DNA N/A
- PRME $179.58
- Revenue Next Year
- DNA $14.41
- PRME N/A
- P/E Ratio
- DNA N/A
- PRME N/A
- Revenue Growth
- DNA 25.21
- PRME 739.42
- 52 Week Low
- DNA $5.00
- PRME $1.11
- 52 Week High
- DNA $16.85
- PRME $6.94
- Technical
- Relative Strength Index (RSI)
- DNA 61.79
- PRME 63.82
- Support Level
- DNA $10.82
- PRME $4.87
- Resistance Level
- DNA $16.82
- PRME $6.94
- Average True Range (ATR)
- DNA 1.11
- PRME 0.49
- MACD
- DNA 0.40
- PRME 0.08
- Stochastic Oscillator
- DNA 69.38
- PRME 55.90
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.